Tectonic Therapeutic, Inc.TECXNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-1.50%
↓ 117% below average
Average (32q)
8.60%
Historical baseline
Range
High:105.50%
Low:-48.45%
Volatility
1790.7%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -1.50% |
| Q2 2025 | 31.83% |
| Q1 2025 | 42.38% |
| Q4 2024 | -36.05% |
| Q3 2024 | 102.39% |
| Q2 2024 | -34.61% |
| Q1 2024 | 50.42% |
| Q4 2023 | -11.58% |
| Q3 2023 | -7.21% |
| Q2 2023 | -48.45% |
| Q1 2023 | 105.50% |
| Q4 2022 | -46.90% |
| Q3 2022 | -15.87% |
| Q2 2022 | -1.76% |
| Q1 2022 | 1.56% |
| Q4 2021 | -18.11% |
| Q3 2021 | 1.91% |
| Q2 2021 | 21.98% |
| Q1 2021 | -5.41% |
| Q4 2020 | -32.38% |
| Q3 2020 | 36.63% |
| Q2 2020 | 14.18% |
| Q1 2020 | 6.13% |
| Q4 2019 | 32.03% |
| Q3 2019 | 6.32% |
| Q2 2019 | -1.44% |
| Q1 2019 | -2.83% |
| Q4 2018 | 38.75% |
| Q3 2018 | 24.64% |
| Q2 2018 | 31.17% |
| Q1 2018 | 0.00% |
| Q3 2017 | 0.00% |
| Q1 2017 | 0.00% |